STAT Plus: FDA extends deadline for stem cell clinics to comply with drug development rules
SÍLVIA A FERREIRA, CRISTINA LOPO AND EILEEN GENTLEMAN, KCL/WELLCOME
The FDA gave clinics that offer stem cell-based treatments six more months to start complying with FDA drug development rules, citing the coronavirus pandemic.
No hay comentarios:
Publicar un comentario